Form 4: Adient CEO Dorlack Boosts Stake with Equity Awards
Insider Transaction Report
Adient plc's President and CEO, Jerome J. Dorlack, reported significant acquisitions of ordinary shares through restricted stock units and performance share units, alongside tax-related dispositions.
Summary
- Jerome J. Dorlack, President and CEO of Adient plc, acquired 212,765 ordinary shares on November 13, 2025, through a grant of restricted stock units (RSUs).
- These RSUs are subject to certain acceleration and forfeiture provisions and will vest in three equal installments on the first, second, and third anniversaries of the grant date.
- An additional 7,559 ordinary shares were acquired on November 13, 2025, representing performance share units (PSUs) earned for the three-year performance period ended September 30, 2025, with approval from the Compensation Committee.
- On November 14, 2025, Dorlack disposed of 28,212 ordinary shares at a price of $20.02 per share to cover taxes due in connection with the vesting of equity awards.
- On November 16, 2025, an additional 3,506 ordinary shares were disposed of at $20.02 per share for tax withholding purposes.
- Following these transactions, Dorlack beneficially owns 629,631 ordinary shares directly.
Sentiment
Score: 7
Explanation: The sentiment is moderately positive. While there are dispositions for tax purposes, the significant grants of restricted stock units and earned performance share units increase the CEO's beneficial ownership, aligning his interests with shareholders. These are routine compensation events.
Positives
- Jerome J. Dorlack, President and CEO, significantly increased his beneficial ownership in Adient plc through the grant of 212,765 restricted stock units and the earning of 7,559 performance share units.
- The acquisition of these equity awards aligns management's interests with those of shareholders, indicating confidence in the company's future performance.
Negatives
- A total of 31,718 ordinary shares were disposed of on November 14 and November 16, 2025, at $20.02 per share, to cover tax obligations related to the vesting of equity awards, reducing direct holdings.
Future Outlook
The restricted stock units granted to Jerome J. Dorlack are scheduled to vest in three equal installments on the first, second, and third anniversaries of the November 13, 2025 grant date, indicating future share issuances.
Industry Context
This Form 4 filing details routine executive compensation and tax-related transactions, which are common across publicly traded companies and do not directly reflect broader industry trends or competitive positioning.
Stakeholder Impact
- Shareholders: The increase in the CEO's beneficial ownership through equity awards generally aligns management's long-term interests with those of shareholders, potentially fostering greater accountability and a focus on long-term value creation.
Next Steps
- The restricted stock units will vest in three equal installments on the first, second, and third anniversaries of the November 13, 2025 grant date.
Key Dates
| Date | Description |
|---|---|
| 2025-09-30 | End of the three-year performance period for which performance share units were earned. |
| 2025-11-13 | Date of earliest transaction; grant of restricted stock units and approval of performance share units. |
| 2025-11-14 | Date of disposition of shares for tax withholding related to equity award vesting. |
| 2025-11-16 | Date of disposition of additional shares for tax withholding related to equity award vesting. |
| 2025-11-17 | Date the Form 4 was signed. |
Recommendation
holdThis Form 4 primarily details routine executive compensation in the form of equity grants and associated tax-related share dispositions. While the increase in insider ownership is a positive signal of alignment, these transactions are expected and do not typically provide new information that would warrant a strong buy or sell recommendation. Therefore, a 'hold' recommendation is appropriate, maintaining current positions based on broader company fundamentals.
Keywords
Adient, ADNT, Form 4, Insider Transaction, Restricted Stock Units, Performance Share Units, Equity Compensation, CEO, Director, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.